血液系统恶性肿瘤患者的姑息治疗:通过整合照护克服困难的策略
本文综述了血液系统恶性肿瘤患者姑息治疗的整合策略,指出该类患者较其他癌症患者接受姑息治疗更少且启动更晚,强调应让所有需要姑息治疗的患者受益于整合照护,并关注沟通策略及输血需求等症状控制等特殊需求,因血液系统恶性肿瘤主要累及高龄人群,特别整合了年龄相关议题。
要点
- 血液系统恶性肿瘤患者较其他癌症患者接受姑息治疗更少且启动更晚。
- 整合姑息治疗可与疾病导向治疗联合,使患者、家属、医护人员和医疗系统获益。
- 需关注沟通策略以帮助患者理解疾病与预后,以及输血需求和症状控制等特殊需求。
核心结论
- 所有需要姑息治疗、临终关怀和终末期照护的患者都应有机会受益于这些照护。
- 血液系统恶性肿瘤患者较其他类型癌症患者接受姑息治疗更少且启动时机更晚。
研究设计与样本
- 本文为系列论文(Series paper),综述血液系统恶性肿瘤患者姑息治疗的整合策略。
主要发现
- 血液系统恶性肿瘤患者较其他类型癌症患者接受姑息治疗更少且启动于更晚的疾病阶段。
- 姑息治疗、临终关怀和终末期照护更紧密整合可使患者、家属、医护人员和医疗系统获益,甚至可与疾病导向治疗联合。
关键数值与推荐
- 血液系统恶性肿瘤患者较其他类型癌症患者接受姑息治疗更少且启动于更晚的疾病阶段。
临床怎么用
- 医生应特别关注与患者沟通的策略,帮助其理解疾病与预后。
- 医生应关注血液系统恶性肿瘤患者的特殊需求,如输血需求和症状控制。
- 因血液系统恶性肿瘤主要累及高龄人群,应整合年龄相关议题。
局限性
- 本文为综述性系列论文,未报告原始研究样本量、效应量或统计检验结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Palliative care, hospice care, and end of life care have been the focus of increased attention over the past two decades; palliative care has shifted from being introduced only at the end of life to becoming an integrated part of routine care for patients. Currently, the timing and extent of the integration of palliative care into standard medical care practice depends on the underlying disease. Patients with haematological malignancies receive less palliative care initiated at a later disease stage compared with patients with other types of cancer. All patients in need of palliative care, hospice care, and end of life care should be given the chance to benefit from these types of care. Patients, their relatives, health-care professionals, and the health-care system can all benefit from the closer integration of palliative, hospice, and end of life care, even in combination with disease orientated treatment. Important factors to consider when introducing palliative care for patients with haematological malignancies are the different treatment strategies for each disease, the heterogeneous dynamics of the different haematological malignancies, the broad variance of therapeutic effects, and patients' dependence on the health-care system for the administration of transfusions and antimicrobial treatment, which is different from patients with solid tumours. Key areas that physicians should pay particular attention to are strategies for communication with patients to aid their understanding of their illness and prognosis and concepts to address special needs of patients with haematological malignancies (eg, transfusion requirements and symptom control). Because haematological malignancies mainly affect patients in advanced age, this Series paper integrates a special focus on age-associated topics.
引用
- Wedding U. Palliative care of patients with haematological malignancies: strategies to overcome difficulties via integrated care. Lancet Healthy Longev. 2021. PMID: 36098031. doi:10.1016/S2666-7568(21)00213-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。